[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100506571":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":38,"collaborators":10,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":10,"eligibilityCriteria":46,"healthyVolunteers":47,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":23,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Salem Anaesthesia Pain Clinic","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Claustrophobic adult patients",null,"Claustrophobic adult patients who are undergoing MRI scan as part of chronic pain management.",[13],{"name":14,"affiliation":5,"role":15},"Olu Bamgbade, MD,FRCPC","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","17786286600","salem.painclinic@gmail.com",[22],{"facility":5,"status":23,"city":24,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"RECRUITING","Surrey","British Columbia","V3S 7J1","Canada","CA",{"type":30,"coordinates":31},"Point",[32,33],-122.82509,49.10635,{"lat":33,"lon":32},[36],{"name":14,"role":18,"phone":37,"phoneExt":10,"email":20},"+17786286600",{"type":39,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100506571","premedication-for-claustrophobic-patients-for-mri-scan-100506571",false,"NCT05876117","Premedication for Claustrophobic Patients for MRI Scan","Clonidine and Lorazepam Premedication for Claustrophobic Patients During MRI Scan","Inclusion Criteria:\n\n* diagnosed with claustrophobia\n* previous incomplete MRI because of claustrophobia\n* adult patients\n* good treatment compliance\n* reliable Claustrophobia Questionnaire (CLQ) diary\n* reliable General Anxiety Disorder Questionnaire (GAD) diary\n* informed consent for diary review\n* consent for clinical record quality assurance review\n\nExclusion Criteria:\n\n* poor treatment compliance\n* cognitive disorder\n* inability to provide consent\n* major neuropsychiatric disorder\n* unreliable diary\n* cannabis use\n* excessive alcohol intake\n* previous adverse\u002Fallergic reactions to clonidine\n* previous adverse\u002Fallergic reactions to lorazepam",true,"ALL","20 Years","99 Years",{"count":52,"type":53},50,"ESTIMATED","OBSERVATIONAL","Claustrophobia is an irrational fear of restriction and suffocation. It is a specific phobia, according to DSM 5. Claustrophobic patients may fear that restriction of their limbs will hinder their ability to move quickly towards safety. MRI may trigger claustrophobia, because this diagnostic procedure involves a patient laying in a narrow tube. Premedication before MRI scan may occasionally reduce claustrophobia.\n\nProspective observational crossover study of claustrophobic patients who are undergoing MRI scan. At alternate MRI scan sessions, each patient receives rotational premedication using Lorazepam 1mg; or Clonidine tablet 0.2mg; or combined Clonidine 0.2mg + Lorazepam 1mg.\n\nPatient will use Claustrophobia Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. CLQ is a patient-administered tool used to assess claustrophobia. In addition, patient will use General Anxiety Disorder Questionnaire, a validated tool, to collect data on the days before and after each MRI scan. GAD-7 is a patient-administered tool that is used to assess anxiety.",[57],"Claustrophobia",[59],"Claustrophobia MRI","2025-01-23",{"date":62,"type":63},"2025-01-27","ACTUAL",{"date":65,"type":63},"2020-07-04",{"date":67,"type":53},"2025-12-31",{"name":5,"class":6},1]